OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2022
(2)
2025
(1)
2023
(1)
2021
(1)
2019
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Immunomarker profiling in human chronic wound swabs reveals IL-1 beta/IL-1RA and CXCL8/CXCL10 ratios as potential biomarkers for wound healing, infection status and regenerative stage.
Not available
S-EPMC11978031
|
biostudies-literature
Cite
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
+
T Cells and Evolve at the Population Level.
Not available
S-EPMC6486497
|
biostudies-literature
Cite
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
Not available
S-EPMC5858626
|
biostudies-literature
Cite
Time Domains of Hypoxia Responses and -Omics Insights
Not available
S-EPMC9400701
|
biostudies-literature
Cite
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186
|
biostudies-literature
Cite
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000
|
biostudies-literature
Cite
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets